Log in
OTCMKTS:SAUHY

Straumann Stock Forecast, Price & News

Lowest-Rated Stocks  
$58.97
-0.14 (-0.24 %)
(As of 01/15/2021 10:01 PM ET)
Add
Compare
Today's Range
$57.15
Now: $58.97▼
$58.97
50-Day Range
$56.52
MA: $58.43▼
$60.60
52-Week Range
$27.34
Now: $58.97▼
$63.07
Volume7,600 shs
Average Volume7,220 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Straumann Holding AG provides tooth replacement and orthodontic solutions worldwide. It researches, develops, manufactures, and supplies dental implant systems, biomaterials, CADCAM prosthetics, digital equipment, software, clear aligner systems, and various materials for dental applications. The company offers dental implant systems for tissue and bone level; titanium, titanium alloy, ceramic, and mini dental implant systems; and guided and non-guided surgical instruments, as well as implant-borne prosthetics. It provides biomaterials, such as bone augmentation materials, membranes, fleeces, and sponges; ceramic healing and screw retained abutments; intraoral scanning solutions; 3D printers; milling machines; and prevention products. In addition, it offers biomaterials, bone substitutes, membranes, biologics, and soft tissue management and oral healing products; digital solutions for dental labs, dentists, and centralized milling centers, as well as materials, third party systems, and guided surgery; surgical instruments comprising surgical and modular cassettes, guided instruments, implant maintenance products, bone block fixation sets, bonerings, titanium pin sets, and other cassettes; and edentulous, pro arch fixed, prosthetic, and mini implant solutions for edentulous patients. Further, it provides esthetic restorations that include ceramic implant monotypes, ceramic implants, abutments, biologics, and other solutions; and Emdogain for wound healing. Further, it offers systems Clear Correct aligners; and training and education services to its customers. The company provides its products to general dentists, specialists, and dental technicians and laboratories, as well as corporate customers, such as distributors, hospitals, universities, and dental service organizations in approximately 100 countries through a network of distribution subsidiaries and partners. Straumann Holding AG was founded in 1954 and is headquartered in Basel, Switzerland.

MarketRank™

Overall MarketRank™

0.40 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:SAUHY
Previous SymbolOTC:SAUHY
CUSIPN/A
CIKN/A
Webwww.straumann.com
Phone41 61 965 11 11
Employees7,273

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable
$58.97
-0.14 (-0.24 %)
(As of 01/15/2021 10:01 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SAUHY News and Ratings via Email

Sign-up to receive the latest news and ratings for SAUHY and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Straumann (OTCMKTS:SAUHY) Frequently Asked Questions

How has Straumann's stock price been impacted by COVID-19?

Straumann's stock was trading at $40.45 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, SAUHY shares have increased by 45.8% and is now trading at $58.97.
View which stocks have been most impacted by COVID-19.

Is Straumann a buy right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Straumann in the last year. There are currently 3 sell ratings, 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" Straumann stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SAUHY, but not buy additional shares or sell existing shares.
View analyst ratings for Straumann or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Straumann?

Wall Street analysts have given Straumann a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Straumann wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Straumann?

Straumann saw a decrease in short interest in December. As of December 31st, there was short interest totaling 2,900 shares, a decrease of 43.1% from the December 15th total of 5,100 shares. Based on an average trading volume of 8,500 shares, the short-interest ratio is currently 0.3 days.
View Straumann's Short Interest.

Who are some of Straumann's key competitors?

Some companies that are related to Straumann include Ambu A/S (AMBBY), Ansell (ANSLY), Ansell (ANSLF), Ansell Limited (ANN.AX) (ANN), BATM Advanced Communications (BTAVF), Carl Zeiss Meditec (CZMWY), Clover Co. Limited (CLV.AX) (CLV), Coloplast A/S (CLPBF), Convatec Group (CNVVY), Demant A/S (WILLF), Essilor International Société Anonyme (EI.PA) (EI), Fisher & Paykel Healthcare (FSPKF), G Medical Innovations Holdings Ltd (GMV.AX) (GMV), Incannex Healthcare Limited (IHL.AX) (IHL) and Iris BioTechnologies (IRSB).
View all of SAUHY's competitors.

Who are Straumann's key executives?

Straumann's management team includes the following people:
  • Dr. Sebastian Burckhardt, Sec. of the Board & Director (Age 66)
  • Mr. Guillaume Daniellot, CEO & Member of Exec. Management Board (Age 50)
  • Dr. Peter Hackel, CFO & Member of Exec. Management Board (Age 51)
  • Mr. Wolfgang Becker, EVP of Emerging Markets & Distributors EMEA and Member of Exec. Management Board (Age 54)
  • Dr. Andreas Meier, Chief Legal Officer, Head of Bus. Devel. & Member of the Exec. Management Board (Age 53)
  • Ms. Petra Rumpf, Head of Dental Service Organizations, EVP of DSO Bus. & Member of the Exec. Management Board (Age 53)
  • Mr. Jens Dexheimer, Head of Sales - Europe & Member of Exec. Management Board (Age 54)
  • Mr. Matthias Schupp, Head of Sales - Latin America & Member of Exec. Management Board (Age 56)
  • Mr. Kok-Kien Loh, Head of Sales - APAC & Member of the Exec. Management Board (Age 53)
  • Mr. Alastair Robertson, Head of Global People Management & Devel. and Member of the Exec. Management Board (Age 60)

What is Straumann's stock symbol?

Straumann trades on the OTCMKTS under the ticker symbol "SAUHY."

How do I buy shares of Straumann?

Shares of SAUHY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Straumann's stock price today?

One share of SAUHY stock can currently be purchased for approximately $58.97.

What is Straumann's official website?

The official website for Straumann is www.straumann.com.

How can I contact Straumann?

The company can be reached via phone at 41 61 965 11 11.

This page was last updated on 1/19/2021 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.